Aptose Reports Fourth Quarter and Year End 2016 Results

Mar 28, 2017 5:03pm EDT

Aptose Announces Planned Departure of Chief Business Officer

Mar 27, 2017 8:00am EDT

Aptose to Participate in Upcoming Investor Conferences

Mar 02, 2017 7:00am EST

Aptose Biosciences to Present at Canaccord Genuity Rare Disease Biopharma 1x1 Day

Feb 02, 2017 7:00am EST

Aptose Prioritizes Development of CG’806 First-in Class FLT3/BTK Inhibitor

Jan 23, 2017 7:00am EST

Aptose Biosciences to Present at Biotech Showcase 2017 Conference

Jan 05, 2017 8:00am EST

Aptose Biosciences Provides Update on APTO-253 Development

Dec 29, 2016 8:00am EST

Aptose Biosciences Reports Financial Results for the Third Quarter Ended September 30, 2016

Nov 14, 2016 7:22pm EST

Aptose To Release Third Quarter Ended September 30, 2016 Financial Results and Hold Conference Call on November 15, 2016

Nov 10, 2016 7:00am EST

Aptose to Present New APTO-253 Data at the 2016 ASH Annual Meeting

Nov 03, 2016 4:15pm EDT